Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Bury

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Journal of Neuropathology and Experimental Neurology|August 9, 2020
Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain CohortAnnabelle Chambers, Joanna J Bury, Thais Minett, et al.
Clinical Lung Cancer|August 13, 2017
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 TrialsHoward L West, James Moon, Antoinette J Wozniak, et al.
Cancer|September 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanomaChristopher D Lao, James Moon, Vincent T Ma, et al.
Menopause (New York, N.Y.)|September 9, 2011
A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7Sandhya Pruthi, Rui Qin, Shelby A Terstreip, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2012
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancerDavid R Spigel, F Anthony Greco, David M Waterhouse, et al.
Cancer|November 19, 2016
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trialLynne I Wagner, Stephanie L Pugh, William Small, et al.
Acta Neuropathologica Communications|March 18, 2017
A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosisJohnathan Cooper-Knock, Claire Green, Gabriel Altschuler, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4Mui Cheung, Weike Bao, David J Behm, et al.
Breast Cancer Research and Treatment|December 28, 2014
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II studyA R Tan, H Johannes, P Rastogi, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitorsKrista B Goodman, Michael J Bury, Mui Cheung, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Journal of Neuropathology and Experimental Neurology|August 9, 2020
Advanced Glycation End Product Formation in Human Cerebral Cortex Increases With Alzheimer-Type Neuropathologic Changes but Is Not Independently Associated With Dementia in a Population-Derived Aging Brain CohortAnnabelle Chambers, Joanna J Bury, Thais Minett, et al.
Clinical Lung Cancer|August 13, 2017
Paired Phase II Studies of Erlotinib/Bevacizumab for Advanced Bronchioloalveolar Carcinoma or Never Smokers With Advanced Non-Small-cell Lung Cancer: SWOG S0635 and S0636 TrialsHoward L West, James Moon, Antoinette J Wozniak, et al.
Cancer|September 29, 2024
Southwest Oncology Group S0826: A phase 2 trial of SCH 727965 (NSC 727135, dinaciclib) in patients with stage IV melanomaChristopher D Lao, James Moon, Vincent T Ma, et al.
Menopause (New York, N.Y.)|September 9, 2011
A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7Sandhya Pruthi, Rui Qin, Shelby A Terstreip, et al.
Lung Cancer (Amsterdam, Netherlands)|September 6, 2012
Phase II trial of ixabepilone and carboplatin with or without bevacizumab in patients with previously untreated advanced non-small-cell lung cancerDavid R Spigel, F Anthony Greco, David M Waterhouse, et al.
Cancer|November 19, 2016
Screening for depression in cancer patients receiving radiotherapy: Feasibility and identification of effective tools in the NRG Oncology RTOG 0841 trialLynne I Wagner, Stephanie L Pugh, William Small, et al.
Acta Neuropathologica Communications|March 18, 2017
A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosisJohnathan Cooper-Knock, Claire Green, Gabriel Altschuler, et al.
ACS Medicinal Chemistry Letters|May 20, 2017
Discovery of GSK2193874: An Orally Active, Potent, and Selective Blocker of Transient Receptor Potential Vanilloid 4Mui Cheung, Weike Bao, David J Behm, et al.
Breast Cancer Research and Treatment|December 28, 2014
Weekly paclitaxel and concurrent pazopanib following doxorubicin and cyclophosphamide as neoadjuvant therapy for HER-negative locally advanced breast cancer: NSABP Foundation FB-6, a phase II studyA R Tan, H Johannes, P Rastogi, et al.
Bioorganic & Medicinal Chemistry Letters|December 9, 2008
Discovery of potent, selective sulfonylfuran urea endothelial lipase inhibitorsKrista B Goodman, Michael J Bury, Mui Cheung, et al.
Pageof 16